Ativo Circulante Alterar Data
Abbott USD 25.51B 488M 2026-03
Amgen USD 31.48B 2.42B 2026-03
Ardelyx USD 381.87M 447K 2026-03
aTyr Pharma USD 67.58M 178.23M 2026-03
Corcept Therapeutics USD 426.03M 59.43M 2026-03
Curis USD 6.92M 7.5M 2025-12
Sanofi EUR 30.95B 8.99B 2025-12
TG Therapeutics USD 1.09B 456.2M 2026-03
United Therapeutics USD 2.87B 830.5M 2026-03
Xoma USD 110.71M 5.78M 2025-09